Graham Capital Management’s MiMedx Group MDXG Stock Holding History

Graham Capital Management’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-35,584	Closed	-$141K	–	1402
2026 Q1	$141K	Sell	35,584 -3,078	-8%	-$15.5K	﹤0.01%	1002
2025 Q4	$262K	Buy	38,662 +16,007	+71%	+$112K	0.01%	923
2025 Q3	$158K	Sell	22,655 -57,720	-72%	-$401K	﹤0.01%	1104
2025 Q2	$491K	Buy	+80,375	New	+$535K	0.01%	835
2024 Q1	–	Sell	-18,719	Closed	-$164K	–	1210
2023 Q4	$164K	Sell	18,719 -2,829	-13%	-$20.7K	﹤0.01%	865
2023 Q3	$157K	Buy	+21,548	New	+$161K	﹤0.01%	893
2022 Q1	–	Sell	-29,656	Closed	-$179K	–	968
2021 Q4	$179K	Buy	+29,656	New	+$206K	0.01%	480

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Graham Capital Management's MDXG Position: Q2 2026 in Review

Graham Capital Management sold out of MiMedx Group (MDXG) in Q2 2026, closing a stake of 35,584 shares — an estimated $141K sold.

Graham Capital Management first reported a position in MDXG in Q4 2021 and held it in 7 quarters. The position peaked at $491K in Q2 2025. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

Graham Capital Management reported no remaining MiMedx Group position as of Q2 2026 after selling out during the quarter.
Graham Capital Management sold 35,584 MiMedx Group shares in Q2 2026, an estimated $141K.
Graham Capital Management first reported a position in MiMedx Group in Q4 2021 and held it in 7 quarters.
Graham Capital Management's MiMedx Group position peaked at $491K in Q2 2025.
226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.